(PRWEB UK) 5 July 2013
Optegra, the specialist eye hospital group, has launched a series of peer review events to bring together optometrists for discussion on key conditions and eye health issues.
To run across the network of hospitals, the first meeting was launched at Optegra Surrey Eye Hospital, in Guildford, the brainchild of Leyana Martin, Optegra’s Professional Partnerships Manager. The two-hour meetings welcome a group of optometrists to discuss a specific subject through interactive discussion, and optometrists gain three CET points for attending.
Attendees bring case studies with them which are relevant to the topic and are then discussed amongst the group. The group is led by one of Optegra’s ophthalmic consultants.
The first meeting was about glaucoma and was led by ophthalmic surgeon Michael Jeffrey, one of Optegra’s specialists in this field. The session specifically looked at different topical therapies, with further meetings planned on ‘OCT – Interpretation and Investigation,’ and ‘The Cornea – when to treat and when to refer.’
Optegra’s Leyana Martin said, “The first Peer Review meeting was extremely well received, and we are creating a lot of interest amongst the optometrist community as they also receive their CET points. It has been such a success that we are due to launch them from some of our hospitals in the North as well, as well as from Optegra Solent Eye Hospital.”
Christopher Hall, Optometrist from C.E.Hall Optometrists Ltd. In Farnham, who attended the Peer Review meeting on glaucoma, said, “When I commenced practice the ophthalmologists rarely communicated with opticians and possibly our diagnostic skills were poor. Glaucoma, and the missing of the onset of the disease is probably every optometrist’s nightmare.”
“It was good to work in a small group and discuss specific patients with the ophthalmologist, discussing how he would have treated the condition. Thanks to excellent mediation everybody was able to raise particular queries and thanks to consultant Mike Jeffrey's advice two patients have now had altered treatment.”
For further information on the peer review meetings, please contact Optegra on 0800 358 0825 or visit http://www.optegra.com.
Note to editors:
Optegra is a specialist provider of ophthalmic services in the UK, Czech Republic, Poland and Germany. Optegra operates 23 eye hospitals and brings together leading-edge research and medical expertise, state-of-the-art surgical equipment and top ophthalmic surgeons renowned for their areas of expertise to offer the best clinical outcomes in laser vision correction, Clarivu (refractive lens exchange), cataract removal, AMD, vitreoretinal and oculoplastics procedures all carried out in five-star patient facilities.
Optegra is committed to the development of eye sciences and championing the latest innovations in vision correction through its dedicated Eye Sciences Division. It achieves this by partnering with leading UK universities in the research and development of the next generation of ophthalmic services and technologies.
In addition, its Professional Partnership Programme of education and development with optometrists and opticians ensures the very best medical treatments are available to all.
To maintain Optegra’s five-star standard of patient care and safety, its specialist eye hospitals draw on the expertise of its Medical Advisory Committees (MAC), headed by consultant level ophthalmic surgeons who all report into the corporate MAC. This is managed by Medical Director Mr. Robert Morris, the renowned refractive expert who determines Optegra’s policies and procedures.
Optegra operates six UK eye hospitals: Optegra Eye Hospital, London; Optegra Surrey Eye Hospital (Guildford); Optegra Birmingham Eye Hospital (Aston); Optegra Yorkshire Eye Hospital (Apperley Bridge and Laser Eye Centre in Leeds City Centre); Optegra Solent Eye Hospital (Whiteley) and Optegra Manchester Eye Hospital, (Didsbury). http://www.optegra.com
For further information/interview/photography, please contact:
Charlotte Sutton, CSPR
T: 01372 270 938
M: 07958 279 240